New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Earlier this year, my wife and I welcomed our son ...

Despite his doctors’ recommendations, President Trump takes a high dose. By Nina Agrawal President Trump takes a high daily dose of aspirin, and has done so for over two decades, rejecting medical ...

Fewer fibromyalgia patients in the duloxetine arm had a discontinuation or switch event within 12 months than in the pregabalin arm (24.3% vs 30.9%). In patients with fibromyalgia, duloxetine showed ...

A new study compared the effects of 30 drugs on cholesterol, blood pressure and weight gain. By Chloe W. Shakin A new large-scale analysis found that the short-term cardiovascular and metabolic side ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

A higher weekly dose of Wegovy achieves even greater weight loss than the standard amount, but this comes with a greater risk of side effects, according to trial results. Prior studies have shown ...

In a recent study published in JAMA Network Open, researchers compared heart failure (HF) incidence between users of gabapentin and pregabalin. Non-opioid medications, such as gabapentin and ...

Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy Many drugs in development continue to follow the historical drug development ...

a The three most commonly used maintenance doses are depicted. b Patients taking 25-50 mg once daily should take one supplemental pregabalin dose of 50 or 75 mg after hemodialysis. c Patients taking ...

The efficacy of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy has been established in several controlled clinical trials. [17,18,19] These trials ...

In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and ...